NeuroSense Therapeutics Ltd. ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced the issuance of a pivotal ...
Data were tested for normality with the Shapiro-Wilk test and for equal variance with Levene test before performing statistical analyses by two-way ANOVA with post-hoc Tukey test for multiple ...